Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Amgen Inc.
*STREET
One Amgen Center Drive
*CITY
Thousand Oaks
*STATE
(Required for U.S. applicants)
California
*COUNTRY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
91320-1799
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Pharmaceutical preparations; pharmaceutical preparations for treatment of oncologic, inflammatory and auto-immune diseases and disorders;
pharmaceutical preparations for treatment of arthritis; pharmaceutical preparations for treatment of diseases and disorders of the blood, skin, bone marrow, nervous system, immune system and joints;
pharmaceutical preparations for treatment of non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), granulomatosis with polyangiitis (GPA), microscopic
polyangiitis (MPA), pemphigus vulgaris (PV), multiple sclerosis (MS), and stem cell transplantation
FILING BASIS
SECTION 1(b)
ATTORNEY INFORMATION
NAME
Richard Y. Kim
ATTORNEY DOCKET NUMBER
100114-0820
FIRM NAME
McDermott Will & Emery LLP
INTERNAL ADDRESS
The McDermott Building
STREET
500 North Capitol Street, N.W.
CITY
Washington
STATE
District of Columbia
COUNTRY
United States
ZIP/POSTAL CODE
20001
PHONE
202-756-8000
FAX
202.756.8087
EMAIL ADDRESS
IPDocketWashington@mwe.com
AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
OTHER APPOINTED ATTORNEY
all others
CORRESPONDENCE INFORMATION
NAME
Richard Y. Kim
FIRM NAME
McDermott Will & Emery LLP
INTERNAL ADDRESS
The McDermott Building
STREET
500 North Capitol Street, N.W.
CITY
Washington
STATE
District of Columbia
COUNTRY
United States
ZIP/POSTAL CODE
20001
PHONE
202-756-8000
FAX
202.756.8087
*EMAIL ADDRESS
IPDocketWashington@mwe.com; rkim@mwe.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
FEE INFORMATION
APPLICATION FILING OPTION
TEAS RF
NUMBER OF CLASSES
1
APPLICATION FOR REGISTRATION PER CLASS
275
*TOTAL FEE DUE
275
*TOTAL FEE PAID
275
SIGNATURE INFORMATION
SIGNATURE
/Stuart L. Watt/
SIGNATORY'S NAME
Stuart L. Watt
SIGNATORY'S POSITION
Vice President, Law and Intellectual Property Officer
DATE SIGNED
11/05/2018
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:88182290
Filing Date:11/05/2018
To the Commissioner for Trademarks:
MARK: RIABNI (Standard Characters, see mark)
The literal element of the mark consists of RIABNI.
The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Amgen Inc., a corporation of Delaware, having an address of
One Amgen Center Drive
Thousand Oaks, California 91320-1799
United States
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Pharmaceutical preparations; pharmaceutical preparations for treatment of oncologic, inflammatory and auto-immune diseases and
disorders; pharmaceutical preparations for treatment of arthritis; pharmaceutical preparations for treatment of diseases and disorders of the blood, skin, bone marrow, nervous system, immune system
and joints; pharmaceutical preparations for treatment of non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), granulomatosis with polyangiitis (GPA),
microscopic polyangiitis (MPA), pemphigus vulgaris (PV), multiple sclerosis (MS), and stem cell transplantation
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The applicant's current Attorney Information:
Richard Y. Kim and all others of McDermott Will & Emery LLP
The McDermott Building
500 North Capitol Street, N.W.
Washington, District of Columbia 20001
United States
202-756-8000(phone)
202.756.8087(fax)
IPDocketWashington@mwe.com (authorized)
The attorney docket/reference number is 100114-0820.
The applicant's current Correspondence Information:
Richard Y. Kim
McDermott Will & Emery LLP
The McDermott Building
500 North Capitol Street, N.W.
Washington, District of Columbia 20001
202-756-8000(phone)
202.756.8087(fax)
IPDocketWashington@mwe.com;rkim@mwe.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at
the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent
application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional
processing fee of $125 per international class of goods/services.
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /Stuart L. Watt/ Date: 11/05/2018
Signatory's Name: Stuart L. Watt
Signatory's Position: Vice President, Law and Intellectual Property Officer
Payment Sale Number: 88182290
Payment Accounting Date: 11/06/2018
Serial Number: 88182290
Internet Transmission Date: Mon Nov 05 18:40:22 EST 2018
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XXX-20181105184022
489136-88182290-61036e1f99f25b691f08f0a8
e335fac4a5b27b53b331a719b8853f5bbca4543c
1-DA-5988-20181024180947580428